Anti-Inflammatory Biologics Market Global Industry Trends, Growth, Share, Size and 2026 Forecast Research Report
The global anti-inflammatory biologics market size is expected to reach USD 149.80 billion by 2027, exhibiting a CAGR of 11.0% during the forecast period. The indication of an inflammatory surplus in patients with COVID-19 along with plentiful neutrophils and macrophages will revivify growth prospects for the anti-inflammatory biologics market share during the forecast period. The ongoing trials for anti-tumor necrosis factor (TNF) antibodies in severe cases of autoimmune inflammatory disease such as rheumatoid arthritis, inflammatory bowel disease, or ankylosing spondylitis will aid the speedy expansion of the market during the forecast period, mentioned by Fortune Business Insights, in a report, titled “Anti-Inflammatory Biologics Market Size, Share & Industry Analysis, By Drug Class (Anti-Tumor Necrosis Factor (TNF), Interleukin Antagonists, Janus Kinase (JAK) Inhibitors, Others), By Application (Rheumatoid Arthritis, Psoriasis, and Others), By Route of Administration (Oral and Injection (Subcutaneous and Intravenous)), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027” the market size stood at USD 64.84 billion in 2019.
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this Market.
Please visit: https://www.fortunebusinessinsights.com/anti-inflammatory-biologics-market-102733
The Report Lists the Prominent Players in the Anti-Inflammatory Biologics Market
- AbbVie Inc.
- Merck & Co., Inc.
- Bristol-Myers Squibb Company
- Johnson & Johnson Services, Inc.
- Pfizer Inc.
- Novartis AG
- UCB S.A.
- Eli Lilly and Company
- Amgen Inc.
Market Driver:
Ongoing Trails for Anti-Tumour Necrosis Factor Therapy to Benefit COVID-19 Patients
The increasing R&D investments by major players for the development of biologics will promote market growth in the forthcoming years. The rising number of deaths from coronavirus (COVID-19) has steered pharmaceutical companies to invest in potential drug candidates. The growing prominence of TNF in acute inflammatory reactions will have a positive impact on the market. Similarly, the ongoing research for anti-TNF therapy in patients with COVID-19 for counteraction and prevention will tremendously influence the market in the forthcoming years. Moreover, the advent of novel biological therapies and monoclonal antibodies by biopharma giants will facilitatethe healthy growth of the marketduring the forecast period. For instance, in December 2019, UCB S.A, a multinational biopharmaceutical company announced positive results from the phase 3 clinical study of Bimekizumab for the treatment of psoriasis. Also, the escalation in applications of existing biologics for rare anti-inflammatory diseases such as lupus, diffuse systemic sclerosis, and others will enhance business scenarios of the market.
TOC:
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Prevalence of Rheumatoid Arthritis & Psoriasis – For Key Countries
- Pipeline Analysis
- Patent Snapshot
- New Product Launches
- Key Industry Developments - Mergers, Acquisitions and Partnerships
- Global Anti-inflammatory Biologics Market Analysis, Insights and Forecast, 2016-2027
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Drug Class
- Anti-Tumor Necrosis Factor (TNF)
- Interleukin Antagonists
- Janus Kinase (JAK) Inhibitors
- Others
- Market Analysis, Insights and Forecast – By Application
- Rheumatoid Arthritis
- Psoriasis
- Other
More Trending Topics from Fortune Business Insights:
Insulin Pump Market Demand, Share, Global Trend, Industry News, Business Growth, Top Key Players, Research Methodology by Forecast to 2027
Nebulizers Market Size, Focuses on Top Companies, Industry Analysis, Share, Size, Growth Forecast to 2026
Pediatric Perfusion Market Analysis, Industry Outlook, Comprehensive Insights, Growth and Forecast 2026
Canine Arthritis Treatment Market Trend, by Top Key Players are Zoetis, Bayer AG, Boehringer Ingelheim International GmbH, Norbrook Others Forecast to 2026